Q
QuantX
Raised $85M in a Series B round, announced 10 February 2026.
Round
QuantX raised US$85 million in a Series B round.
- Amount
- $85M
- Stage
- Series B
- Announced
- 10 February 2026
- Leads
- LAV, Sanofi Ventures
- Other investors
- Hongshan
- Use of funds
- Clinical development of its STAT6 and IL-17 oral small molecule inhibitors, plus continued discovery efforts.
- Total raised
- $130M to date
- Checked
- Amount and date checked against the press source
Company
Develops oral small-molecule medicines using computationally driven drug discovery platform for immune and inflammatory diseases.
- Based in
- Princeton
- Founded
- 2022
- Sector
- Health
- Website
- quantxbio.com ↗
Founders
- Wayne Tang, Ph.D.co-founder
- Yax Sun, Ph.D.co-founder
- Wei Li, Ph.D.Interim Chief Executive Officer
